Hepatocellular cancer Trials in Los Angeles, United States
Conditions / Hepatocellular cancer / Los Angeles, United States
Hepatocellular cancer has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05293496 | A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT00997022 | Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients | COMPLETED | PHASE1 |
| NCT05438420 | Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT05064553 | ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk | ACTIVE_NOT_RECRUITING | — |
| NCT06858813 | A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC) | RECRUITING | PHASE1 |
| NCT00669136 | Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma | TERMINATED | PHASE1 |
| NCT05701488 | SIRT With Tremelimumab and Durvalumab for Resectable HCC | RECRUITING | PHASE1 |
| NCT02954094 | A Longitudinal Observational Study of the Natural History and Management of Patients With HCC | ACTIVE_NOT_RECRUITING | — |
| NCT03132792 | AFPᶜ³³²T in Advanced HCC | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT02069145 | Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer | COMPLETED | PHASE1 |